Why Is CIPHER DIGITAL INC (CIFR) Stock Up Today?

Cipher Digital Inc (CIFR) shares rose 11.44% to $7.65 on Monday. The primary driver was a technology integration announcement with BIO-key, which followed a wave of analyst price target reductions after the company’s third-quarter earnings release.

What Happened

Cipher and BIO-key announced a technology integration to expand their identity security offering, starting in Portugal. The partnership was disclosed via a press release from Lisbon and Holmdel, New Jersey. This news arrived after a series of rating actions from major banks. Northland lowered its price target to $14 from $27.50. Cantor Fitzgerald cut its target to $15 from $19. Wells Fargo reduced its target to $15 from $25. JPMorgan lowered its target to $18 from $22, citing valuation concerns. Needham and Rosenblatt also maintained Buy ratings while lowering their respective targets to $15 and $19.

The company’s Q3 2026 earnings call highlighted $16.6 billion in contracted revenue and a $5.2 billion lease extension at Barber Lake. However, reported revenue of $26.7 million missed estimates of $38.5 million and fell 63% year over year. Earnings per share of negative $0.22 beat the estimate of negative $0.26.

What The Data Shows

The stock opened at $6.95, a 1.3% gap up from the prior close of $6.86. It reached a session high of $7.76 at 9:50 AM ET and a low of $6.91 at 7:00 AM ET. Volume stood at 12.7 million shares, which is 0.4 times the three-month daily average. The stock has a market capitalization of $3.0 billion and a beta of 3.21. It is unprofitable with a trailing twelve-month EPS of negative $2.79, though revenue grew 20.3% over the same period. The 52-week range is $6.62 to $30.14. Over the last eight sessions, the stock had declined 17.5% from $8.32 to $6.86. Unusual options activity included six notable prints with $3.6 million in call premium and no put premium, with the largest single print at $1.1 million.

What To Watch

Retail traders on social platforms are discussing the earnings miss and the new partnership. The stock printed 15 fresh 52-week highs on November 3, 2026. Investors will monitor how the BIO-key integration impacts future revenue projections and whether the recent price target cuts signal a broader valuation reset for the stock.